Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions The Panic-Proof Portfolio (Stockchase Research)
CorMedix Inc.CRMDPAST TOP PICKNov 25, 2025
$9.32
Stock price when the opinion was issued
$8.74
As of Jun 12, 2026. Market Open.
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentTOP PICK
Stockchase Research Editor: Michael O'Reilly
CRMD is beginning to see fruit of its antimicrobial catheter lock -- the first and only in the heath space introduced in last year -- that has been clinically proven to reduce infection by over 70% (a BIG cost saver to health plans). It trades at 17x earnings, 4x book and supports a robust 38% ROE. We recommend setting a stop-loss at $9.50, looking to achieve $17.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $19.50)Healthcare
Our PAST TOP PICK with CRMD has triggered its stop at $9.50. To remain disciplined, we recommend covering the position at this time.